HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Olaf Sommerburg Selected Research

Pancreatitis-Associated Proteins

1/2020Pancreatitis-Associated Protein in Neonatal Screening for Cystic Fibrosis: Strengths and Weaknesses.
3/2017[Newborn Screening on Cystic Fibrosis in Germany: Comparison of the new Screening Protocol with an Alternative Protocol].
11/2016A product of immunoreactive trypsinogen and pancreatitis-associated protein as second-tier strategy in cystic fibrosis newborn screening.
10/2010Initial evaluation of a biochemical cystic fibrosis newborn screening by sequential analysis of immunoreactive trypsinogen and pancreatitis-associated protein (IRT/PAP) as a strategy that does not involve DNA testing in a Northern European population.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Olaf Sommerburg Research Topics

Disease

17Cystic Fibrosis (Mucoviscidosis)
11/2022 - 01/2009
8Lung Diseases (Lung Disease)
03/2021 - 09/2003
2Pneumonia (Pneumonitis)
03/2021 - 01/2015
2Inflammation (Inflammations)
01/2021 - 01/2021
1Meconium Ileus
01/2022
1Infections
09/2021
1Exocrine Pancreatic Insufficiency
03/2021
1Hypervitaminosis A
03/2021
1Dysbiosis
01/2021
1Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2021
1Disease Progression
11/2020
1Abscess
01/2020
1Empyema
01/2020
1Rhinosinusitis
11/2016
1Dehydration (Water Stress)
11/2014
1Emphysema
11/2014
1Neoplasms (Cancer)
01/2009
1Lung Neoplasms (Lung Cancer)
09/2003

Drug/Important Bio-Agent (IBA)

5Cystic Fibrosis Transmembrane Conductance Regulator (Protein, CFTR)IBA
01/2022 - 09/2020
4Pancreatitis-Associated ProteinsIBA
01/2020 - 10/2010
3ivacaftor drug combination tezacaftorIBA
11/2022 - 01/2022
3elexacaftorIBA
11/2022 - 01/2022
3ivacaftorIBA
03/2021 - 11/2015
3TrypsinogenIBA
03/2017 - 10/2010
3Carotenoids (Carotene)IBA
01/2015 - 09/2003
2Interleukin-8 (Interleukin 8)IBA
09/2021 - 01/2021
2Vitamin A (Retinol)FDA LinkGeneric
03/2021 - 01/2015
2lumacaftorIBA
03/2021 - 01/2021
2LipidsIBA
03/2021 - 01/2015
2VitaminsIBA
03/2021 - 01/2015
1ChloridesIBA
01/2022
1Interleukin-6 (Interleukin 6)IBA
09/2021
1CytokinesIBA
09/2021
1Immunoglobulin G (IgG)IBA
03/2021
1Biomarkers (Surrogate Marker)IBA
01/2021
1Methionine-tRNA LigaseIBA
11/2020
1NitrogenIBA
10/2020
1Contrast MediaIBA
01/2020
1dornase alfa (Pulmozyme)FDA Link
11/2016
1AerosolsIBA
11/2016
1AntioxidantsIBA
01/2015
1Palm OilIBA
01/2015
1SmokeIBA
11/2014
1Matrix Metalloproteinases (MMPs)IBA
11/2014
1Matrix Metalloproteinase 12IBA
11/2014
1DNA (Deoxyribonucleic Acid)IBA
10/2010

Therapy/Procedure

8Therapeutics
11/2022 - 04/2014
1PPA protocol
01/2022